IGC Pharma, Inc. (IGC)
NYSE: IGC · Pharmaceutical Preparations · Potomac, MD · filing with the SEC since 2005
Filings
209 filings since 2017 beside 103 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-KT
Annual report, transition period for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by May 15, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Oct 22, 2026.
Filings a yearinsider forms included
1432311924373125
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 1 time in the last 36 months, the newest Mar 13, 2024.SEC letters: 8 in the last 36 months, the newest Dec 4, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Jul 6, 2026
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Jun 30, 2026
Jun 8, 2026
8-K items 1.01, 2.03, 9.01
Major agreement signed; New debt or obligation taken on · Current report
Jun 5, 2026
Apr 20, 2026
8-K items 1.01, 2.03, 3.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Apr 14, 2026
Mar 12, 2026
8-K items 1.01, 2.03, 3.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Mar 6, 2026
Dec 15, 2025
8-K items 5.03, 9.01
Charter, bylaw or fiscal-year change · Current report
Dec 12, 2025
Nov 14, 2025
8-K items 2.01, 9.01
Purchase or sale of a business completed · Current report
Nov 13, 2025
Sep 27, 2024
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Sep 25, 2024
40 of 209 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.